Our pipeline banner


Pipeline Overview

We have a strong pipeline of candidates to treat food, gastrointestinal (GI), and metabolic-related diseases, developed in-house or in collaboration with leading biotechnology companies. We’re collaborating in Research & Development (R&D) across the health care ecosystem to expand our portfolio of groundbreaking treatments and deliver on our promise of bringing innovative medicines to patients in need.

Our Pipeline in the Allergy Space Continues to Drive Innovation for Patients
Our GI Pipeline is Poised to Deliver New Products in 2023+